Venlafaxine: Oos Result For Spheroids Dissolution Rate Profile (drp)

Venlafaxine Recall Summary Taro Venlafaxine XR tablets are being recalled across Canada because test results show the medication may not dissolve at the proper rate in the body. This is a Class I recall, meaning the product could cause serious health consequences. The recall affects venlafaxine extended-release products distributed by Taro throughout Canada.

Product
TARO-VENLAFAXINE XR
Reason
Product quality
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2022-09-21
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/a7ad2d02-0f82-42fb-a5b1-d08fe1acd54f